Deep Knowledge Ventures, a firm that focuses on age-related disease drugs and regenerative medicine projects, says the program, called VITAL, can make investment recommendations about life sciences firms by poring over large amounts of data.More info here.
Just like other members of the board, the algorithm gets to vote on whether the firm makes an investment in a specific company or not. The program will be the sixth member of DKV's board.
Wednesday, June 11, 2014
VC Firm Names Algorithm To Its Board Of Directors
"Venture Capital Firm Just Named An Algorithm To Its Board Of Directors"